STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
61
13F, latest reported quarter
AIRS filings, in plain words
Read the full summary
The latest 5% ownership filing is a 13D by Rollins Aaron, filed 2026-03-13, for 23.6% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Airsculpt Technologies insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for Airsculpt Technologies, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$150.7M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM AIRS
FY Dec 2025
$151.8M
FY Dec 2024
$180.3M
FY Dec 2023
$195.9M
FY Dec 2022
$168.8M
FY Dec 2021
$133.3M
Jun 2026
$42.9M
Mar 2026
$39.4M
Dec 2025
$33.4M
Sep 2025
$35.0M
Jun 2025
$44.0M
Mar 2025
$39.4M
Dec 2024
$39.2M
Sep 2024
$42.5M
At each fiscal year end
Single quarter
Net margin, TTM
-7.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM AIRS
FY Dec 2025
-7.7%
FY Dec 2024
-4.4%
FY Dec 2023
-2.2%
FY Dec 2022
-8.7%
FY Dec 2021
n/a
Jun 2026
-2.6%
Mar 2026
-6.1%
Dec 2025
+3.8%
Sep 2025
-27.2%
Jun 2025
-1.3%
Mar 2025
-7.2%
Dec 2024
-12.3%
Sep 2024
-14.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$760.0K
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM AIRS
FY Dec 2025
$692.0K
FY Dec 2024
-$2.7M
FY Dec 2023
$14.0M
FY Dec 2022
$11.5M
FY Dec 2021
$19.5M
Jun 2026
-$1.5M
Mar 2026
$5.2M
Dec 2025
-$2.6M
Sep 2025
-$405.0K
Jun 2025
$4.7M
Mar 2025
-$1.0M
Dec 2024
-$815.0K
Sep 2024
-$3.1M
At each fiscal year end
Single quarter
Debt to equity
0.42x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity AIRS
FY Dec 2025
0.64x
FY Dec 2024
0.89x
FY Dec 2023
0.87x
FY Dec 2022
1.18x
FY Dec 2021
0.99x
Jun 2026
0.42x
Mar 2026
0.45x
Dec 2025
0.64x
Sep 2025
0.69x
Jun 2025
0.64x
Mar 2025
0.90x
Dec 2024
0.89x
Sep 2024
0.85x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.03x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt AIRS
FY Dec 2025
0.06x
FY Dec 2024
0.16x
FY Dec 2023
0.33x
FY Dec 2022
0.29x
FY Dec 2021
0.32x
Jun 2026
0.03x
Mar 2026
0.17x
Dec 2025
0.06x
Sep 2025
0.15x
Jun 2025
0.18x
Mar 2025
0.13x
Dec 2024
0.16x
Sep 2024
0.19x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-12.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity AIRS
FY Dec 2025
-14.1%
FY Dec 2024
-10.0%
FY Dec 2023
-5.5%
FY Dec 2022
-19.0%
FY Dec 2021
n/a
Jun 2026
-12.0%
Mar 2026
-12.7%
Dec 2025
-14.1%
Sep 2025
-21.6%
Jun 2025
-16.3%
Mar 2025
-21.2%
Dec 2024
-10.0%
Sep 2024
-9.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-6.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets AIRS
FY Dec 2025
-5.8%
FY Dec 2024
-3.8%
FY Dec 2023
-2.1%
FY Dec 2022
-7.3%
FY Dec 2021
n/a
Jun 2026
-6.0%
Mar 2026
-5.7%
Dec 2025
-5.8%
Sep 2025
-9.0%
Jun 2025
-7.0%
Mar 2025
-8.3%
Dec 2024
-3.8%
Sep 2024
-3.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital AIRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
+10.3%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-7.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed AIRS
FY Dec 2025
-6.7%
FY Dec 2024
-0.9%
FY Dec 2023
+5.4%
FY Dec 2022
-2.5%
FY Dec 2021
+8.9%
Jun 2026
-7.6%
Mar 2026
-7.0%
Dec 2025
-6.7%
Sep 2025
-8.4%
Jun 2025
-4.7%
Mar 2025
-7.9%
Dec 2024
-0.9%
Sep 2024
+2.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing AIRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$116.3M
market value at close 2026-10-27 on 2026-08-07 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value AIRS
FY Dec 2025
$171.2M
FY Dec 2024
$361.9M
FY Dec 2023
$491.0M
FY Dec 2022
$281.8M
FY Dec 2021
$1.0B
Jun 2026
$342.2M
Mar 2026
$227.8M
Dec 2025
$171.2M
Sep 2025
$552.3M
Jun 2025
$333.5M
Mar 2025
$199.7M
Dec 2024
$361.9M
Sep 2024
$356.2M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+0.8%
TTM free cash flow over market value at close 2026-10-27
FCF yield AIRS
FY Dec 2025
+0.6%
FY Dec 2024
-0.9%
FY Dec 2023
+3.3%
FY Dec 2022
+5.5%
FY Dec 2021
+2.0%
Jun 2026
+0.2%
Mar 2026
+3.5%
Dec 2025
+0.6%
Sep 2025
+0.5%
Jun 2025
-0.1%
Mar 2025
-4.0%
Dec 2024
-0.9%
Sep 2024
+0.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing AIRS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
AIRS ranks highest on financial health (44th percentile) and risk and compliance (42nd), and lowest on growth (13th), among Healthcare Services peers.
Profitability
40
Inputs
Return on equity-12.0% · 41 pct, sector of 70
Return on assets-6.0% · 43 pct, sector of 88
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed-7.6% · 37 pct, sector of 68
Financial health
44
Inputs
Debt to equity0.42x · 50 pct, sector of 61
Cash flow to debt0.03x · 38 pct, sector of 66
Growth
13
Inputs
Revenue growth, YoY-15.8% · 13 pct, sector of 87
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
22
Inputs
Funds adding, latest quarter61 · 22 pct, sector of 73
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
42
Inputs
Short interest, % of float+17.9% · 11 pct, sector of 95
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+6.9% · 73 pct, sector of 72
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.